Business Insights, Oct 2011, Pages: 92
drivers of uptake for specific drugdelivery routes including, oral, transdermal, pulmonary, and injectable.
- Using case studies understand how to take a strategic approach to drugdelivery based product
Jain PharmaBiotech, Feb 2012, Pages: 772
penetration is improved in transdermaldrugdelivery. A particularly effective application is as nonviral gene therapy vectors. Nanotechnology has the potential to provide controlled release devices
GBI Research, Sep 2011, Pages: 120
Inhalers and Infusion Pumps to be Key Revenue Generators” provides key data, information and analysis on the globaldrugdelivery device market. The report provides the market landscape, competitive
Business Insights, May 2008, Pages: 175
in the globaldrugdelivery market with this report’s analysis of market size and growth, the commercial value of drugdelivery systems and the extended strategic focus of growing numbers of drugdelivery
Cientifica Ltd., Sep 2007, Pages: 301
Within The Drug Encapsulation/DrugDelivery/Drug Targeting Sector
Exhibit 19: Estimated Global Production Rates For Various Nanomaterials And Devices (2003–2004)
Exhibit 20: Average Technology Targets
Business Insights, Jan 2009, Pages: 138
products.
Active transdermal technologies have generated the greatest number of technologies and devices amongst large molecule delivery innovations, with 16 clinical and 8 preclinical drug/device
PharmaVision, Dec 2007, Pages: 100
.
Newer delivery methods such as transdermaldrugdelivery which can employ nanotechnology to increase absorption and bioavailability, as well as being non-invasive and simple to use are on the rise
MP Advisors, Aug 2011
of delivery of drug
- Efficacy and safety data
- Hydrogel Technology
- ACP-03 – Transcon Linker and Hydrogel Technology
- Inhalation Powder
- Advantages of MKC 253
- Transdermal patch
- VioDor – RF
PharmaVision, Sep 2007, Pages: 94
technologies use to deliver insulin25
Table 7.1: Leading drugdelivery specialists in buccal, oral, transdermal and nasal diabetes delivery research63
Table 10.1: Global prevalence of diabetes (200682
Table 10
Frost & Sullivan, Dec 2004
, parenteral, transdermal, and inhalation drugdelivery technologies. In addition to evaluating research trends in key companies and universities across the globe, this study evaluates the important technology
Cientifica Ltd., June 2008, Pages: 1027
delivery, food, textiles and energy.
- New Data: on government funding, market sizes and rates of growth for key market sectors
- New Economic Model: The author’s model includes global and corporate R
GlobalData, May 2011, Pages: 124
North America DrugDelivery Devices Market Outlook to 2017
Summary
GlobalData’s new report, “North America DrugDelivery Devices Market Outlook to 2017” provides key market data on the North
GlobalData, Nov 2010, Pages: 129
United States and Canada.
- Market size and company share data for DrugDelivery Devices market categories – Inhalation Systems, Infusion Systems and Needle Free Injections.
- Annualized market revenues (USD
Datamonitor, Aug 2010, Pages: 223
, Johnson & Johnson)
Drug overview
Market-leading transdermal patch retains significant share despite generic competition
Drug profile
Product positioning
Distinction from major oral brands has allowed
Datamonitor, July 2010, Pages: 163
interest is low in migraine
A wide variety of delivery methods are present in the migraine pipeline
5. Pipeline Analysis and Forecasts: Acute Migraine Drugs
Key findings
Overview of acute migraine
GlobalData, May 2011, Pages: 141
and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for DrugDelivery
